On April 16, 2020, the American Cancer Society announced the recipients of this year’s research and training grants. These grants are mostly new grants that are awarded to new researchers that are taking risks in their research and developing innovative ideas.
Medicine at the Intersection of Technology and Treatment
Scientists are increasingly working in fields that sit at the intersection of science and technology. They need to investigate many different scientific fields for new discoveries. Dr. Cassandra E. Callmann, a recipient of the American Cancer Society’s grant, is a prime example of how science and technology research converge.
Dr. Callmann is conducting research on the use of nanotechnology to accelerate the development of a vaccine for triple-negative breast cancer. Triple-negative breast cancer is a more aggressive form of breast cancer where the growth rate is not associated with hormones such as estrogen and progesterone. This research requires studying material science, chemistry, and biology, and analyzing how they are all connected.
Using ResoluteAI’s Foundation, researchers can easily trace Dr. Callmann’s progress through interactive searches:
Intelligent Discovery Drives Innovation
Traditional cancer research is increasingly transformed by technological innovations. Scientists like Dr. Callmann are becoming the norm; they understand and proactively discover ways to connect research using techniques borrowed from diverse science and engineering fields.
ResoluteAI’s discovery engine is uniquely architected for scientific research. Researchers who are new to working at the intersection of science and technology are guided with user-friendly, intuitive search options. To expand the way researchers’ minds work, they need intelligent research tools that encourage discoveries across technology, engineering, and all other scientific fields.
